|
-
|
-
|
|
|
|
|
|
|
210-418-7
|
615-28-1
|
|
|
|
|
|
|
202-430-6
|
95-54-5
|
|
|
|
|
|
|
209-025-3
|
552-89-6
|
|
|
|
|
|
|
201-855-4
|
88-74-4
|
|
|
|
|
|
|
434-350-4
|
103122-66-3
|
|
|
|
Annex 17 Appendix 2; Annex 17 Appendix 4
|
|
|
432-750-3
|
109202-58-6
|
|
|
|
Annex 17 Appendix 2; Annex 17 Appendix 4
|
|
ETA; ETA 50 (50 %IGE ZUBEREITUNG); O-ETHYLHYDROXYLAMINE
|
402-030-3
|
624-86-2
|
|
|
|
|
|
|
218-276-8
|
2104-64-5
|
|
|
|
|
|
|
-
|
-
|
|
|
|
|
|
|
202-423-8
|
95-48-7
|
|
|
|
|
|
|
227-534-9
|
5873-54-1
|
|
|
|
|
|
|
221-817-0
|
3244-90-4
|
|
|
|
|
|
KENODOX
|
404-300-6
|
116753-76-5
|
|
|
|
|
|
DP 211
|
406-940-1
|
126019-82-7
|
|
|
|
|
|
ASIL-322; OS-5200
|
421-870-1
|
156145-66-3
|
|
|
|
|
|
|
-
|
-
|
|
|
|
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
|
HWS-130
|
410-140-8
|
127244-43-3
|
|
|
|
|
|
VULKANISATIONSBESCHLEUNIGER VP KA 9124
|
404-380-2
|
110799-28-5
|
|
|
|
|
|
LORATADINE INTERMEDIATE; LRD-A
|
406-720-5
|
32998-95-1
|
|
|
|
|
|
|
-
|
-
|
|
|
|
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
|
|
-
|
2163-79-3
|
|
|
|
|
|
|
213-589-6
|
991-42-4
|
|
|
|
|
|
1 - 2.5 moles ethoxylated
|
500-209-1
|
68412-54-4
|
|
|
|
|
|
|
-
|
-
|
|
|
|
|
|
|
203-931-2
|
112-05-0
|
|
|
|
|
|
|
-
|
-
|
|
|
|
|
B Bacteria and similar species
|
|
-
|
-
|
|
|
|
|
B Bacteria and similar species
|
|
-
|
-
|
|
|
|
|
B Bacteria and similar species
|
|
-
|
-
|
|
|
|
|
B Bacteria and similar species
|
|
-
|
-
|
|
|
|
|
B Bacteria and similar species
|
|
-
|
60999-18-0
|
|
|
|
|
|
|
210-698-0
|
621-64-7
|
|
|
|
|
|
|
200-876-6
|
75-52-5
|
|
|
|
|
|
|
233-272-6
|
10102-44-0
|
|
|
|
|
|
|
217-406-0
|
1836-75-5
|
|
|
|
Annex 17 Appendix 2; Annex 17 Appendix 6
|
|
|
201-188-9
|
79-24-3
|
|
|
|
|
|
DABCO X-412
|
413-670-8
|
103969-79-5
|
|
|
|
|
|
|
238-076-4
|
14216-75-2
|
|
|
|
Annex 17 Appendix 1; Annex 17 Appendix 6
|
|
|
231-714-2
|
7697-37-2
|
|
|
|
|
|
|
231-714-2
|
7697-37-2
|
|
|
|
|
|
|
217-682-2
|
1929-82-4
|
|
|
|
|
|
|
200-193-3
|
54-11-5
|
|
|
|
|
|
|
231-111-4
|
7440-02-0
|
|
|
|
|
|
|
231-111-4
|
7440-02-0
|
|
|
|
|
|
|
240-235-8
|
16083-14-0
|
|
|
|
Annex 17 Appendix 1; Annex 17 Appendix 6
|
|
|
231-827-7
|
7757-95-1
|
|
|
|
|
|
|
218-744-1
|
2223-95-2
|
|
|
|
Annex 17 Appendix 1; Annex 17 Appendix 6
|
|
|
244-578-4
|
21784-78-1
|
|
|
|
|
|
|
233-263-7
|
10101-96-9
|
|
|
|
|
|
|
|
|
|
|
|
|
|